At the postsynaptic membrane of glutamatergic synapses, the cAMP-dependent protein kinase (PKA), protein kinase C (PKC), and calcineurin (CaN) anchoring protein AKAP79/150 is recruited to NMDA and AMPA glutamate receptors by postsynaptic density (PSD)-95 family membrane-associated guanylate kinase (MAGUK) scaffold proteins. These signaling scaffold complexes may function to regulate receptor phosphorylation in synaptic plasticity. Thus, it is important to understand regulation of AKAP79/150 targeting to synapses and recruitment to PSD-MAGUK complexes. AKAP79 is targeted to the plasma membrane by an N-terminal basic domain that binds phosphatidylinositol-4,5-bisphosphate (PI-4,5-P 2 ) and is regulated by PKC phosphorylation and calmodulin binding. Here we demonstrate that this same domain also binds F-actin in a calmodulin-and PKC-regulated manner, targets to membrane ruffles enriched in F-actin and PI-4,5-P 2 in COS7 cells, and localizes to dendritic spines with F-actin and PSD-MAGUKs in hippocampal neurons. Inhibition of actin polymerization disrupted AKAP79 targeting of PKA and CaN to ruffles in COS7 cells and endogenous AKAP79/150 dendritic spine localization with PKA, CaN, and PSD-MAGUKs in neurons. AKAP79/150 postsynaptic localization was rapidly regulated by NMDA receptors through CaN activation and F-actin remodeling, further suggesting that AKAP79/150 signaling scaffold targeting depends on actin dynamics. NMDA receptor activation also regulated dendritic spine localization of PKA and CaN and association of the AKAP79/150-PKA complex with PSD-MAGUKs. Because AMPA receptor PKA phosphorylation and synaptic localization are regulated by similar NMDA receptor-CaN signaling pathways linked to hippocampal long-term depression, this regulation of AKAP79/150 postsynaptic targeting might be important for synaptic plasticity.
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Key words: postsynaptic density; actin; PSD-95 MAGUKs; AKAPs; PKA; calcineurin; NMDA and AMPA receptors NMDA and AMPA glutamate receptors form complexes with cytoskeletal and scaffold proteins in the postsynaptic density (PSD) (Kennedy, 1997; Ziff, 1997) . Prominent among these scaffolds are PSD-95 family membrane-associated guanylate kinases (PSD-MAGUKs) containing postsynaptic density-95, discs large, zona occludens-1 (PDZ), Src homology-3 (SH3), and guanylate kinase (GK) domains. Through binding MAGUKs and additional proteins, receptors are linked to intracellular signaling pathways and the actin cytoskeleton (Sheng and Scala, 2001) . It is believed that regulation of this molecular architecture is essential for controlling glutamate receptors in hippocampal long-term potentiation (LTP) and long-term depression (LTD) synaptic plasticity (Luscher et al., 2000; Tomita et al., 2001) .
Recent studies have shown that AMPA receptors are rapidly recruited to synapses by exocytosis during NMDA receptordependent LTP and rapidly removed from synapses by endocytosis during LTD through pathways involving PDZ scaffolds and F-actin (Carroll et al., 2001; Sheng and Lee, 2001) . AMPA receptor activity and phosphorylation are also bi-directionally regulated during LTP and LTD by calcium/calmodulindependent protein kinase II (CaMKII), cAMP-dependent protein kinase (PKA), protein phosphatase 2B-calcineurin (CaN), and protein phosphatase 1 (PP1) (Mulkey et al., 1994; Barria et al., 1997 , Lee et al., 1998 , 2000 Morishita et al., 2001) . Importantly, these kinases and phosphatases also regulate receptor trafficking in plasticity; for instance, synaptic delivery of AMPA receptors during LTP requires CaMKII (Hayashi et al., 2000; Shi et al., 2001 ). In addition, AMPA receptor endocytosis under LTD conditions requires CaN, and receptor recycling requires PKA (Beattie et al., 2000; Ehlers, 2000) .
Mechanisms regulating PKA and CaN localization that are likely to be important for coordinating AMPA receptor phosphorylation and trafficking have not been studied extensively. Human A-kinase anchoring protein (AKAP) 79/rat AKAP150 (AKAP79/150) is a postsynaptic scaffold protein for PKA and CaN that may play an important role in these processes (Bregman et al., 1989; Carr et al., 1992; Coghlan et al., 1995) . AKAP79/150 binds to PSD-95 and synapse-associated protein (SAP)97 MAGUKs in complexes with NMDA and AMPA receptors, respectively (Colledge et al., 2000) . AKAP-PKA anchoring regulates AMPA-receptor activity in hippocampal neurons and GluR1 subunit phosphorylation through SAP97 in transfected cells (Rosenmund et al., 1994; Colledge et al., 2000; Tavalin et al., 0.2% Triton X-100 in PBS (10 min). C ells were then washed with PBS and blocked in PBS ϩ 10% BSA for 30 -60 min. The primary antibodies were incubated for 1-2 hr at room temperature in PBS ϩ BSA. Primary antibodies were used as follows: 1:500 rabbit anti-AK AP150, 1:1000 rabbit anti-AK AP79 (Dr. Yvonne Lai, IC OS, Bothel, WA); 1:100 mouse anti-PSD-95 (ABR, Golden, C O); 1:500 mouse anti-synapsin (Chemicon, Temulca, CA); 1:100 mouse anti-GABA A receptor (Chemicon); 1:200 anti-myc-9E10 (Santa Cruz Biotechnologies, Santa Cruz, CA); 1:100 rabbit anti-GluR1 (UBI, Lake Placid, N Y); 1:200 mouse pan-anti-PSD-M AGUK family (UBI); 1:200 mouse anti-PK A-RII␤ (Transduction Labs, L os Angeles, CA); 1:500 mouse anti-C aN B (UBI). After incubation with primary antibodies the cells were washed extensively in PBS ϩ BSA and incubated for 1 hr with fluorescent secondary antibody conjugates [goat anti-mouse-or goat anti-rabbit-Texas Red 1:250, -FI TC 1:500, or -C y5 1:250 (Molecular Probes, Eugene, OR, or Jackson ImmunoResearch, West Grove, PA) or Texas Red-phalloidin 1:200 (Molecular Probes)]. Coverslips were then washed in PBS and water and mounted on glass slides with Pro-long (Molecular Probes). For the AK AP79 -CFP/ PLC␦-PH-YFP colocalization studies, C OS7 cells were placed in a chamber (Molecular Probes) for live cell imaging. Specific indirect fluorescence and intrinsic GFP, CFP, or YFP fluorescence were detected with chroma filter sets using a Nikon TE-300 inverted microscope (100Xplan-apo, oil, 1.4 numerical aperture) equipped with Micromax or Sensicam digital CCD camera and Slidebook 3.0 software (Intelligent Imaging Innovations, Denver, C O). Images were exported from Slidebook as TI FF files and assembled using Adobe Photoshop 5.5.
Image quantitation was performed in Slidebook using Masks and Segmentation. Briefly, for calculation of normalized mean fluorescence intensities for immunostaining, both red-Texas Red and green-FI TC channels were segmented together to generate a total neuron mask (T) including only areas of continuous pixels corresponding to the cell(s) of interest with background removed. A separate mask was drawn for the soma (S) and subtracted from the T mask to generate a dendrite (D) mask. Mean fluorescence intensities were calculated from the D and S masks for each channel and expressed as a ratio (%D/S) as well as normalized to corresponding values for the T mask (%D/ T or %S/ T). These normalized mean intensity ratios calculated from multiple images are expressed as average percentages Ϯ SEM in Results or in the bar graphs in the figures. For AK AP79 -GFP neuron expression studies, separate masks were drawn manually for dendritic spine heads and dendrite shafts in each image. Mean fluorescence intensities were then calculated for these masks for each image to generate a normalized ratio of spine/shaft GFP fluorescence. These normalized ratios for multiple images were then averaged and are reported Ϯ SEM in the text. An average spine/shaft ratio of 1 was seen for untargeted GFP; thus ratios Ͼ1 seen for the AK AP-GFPs reflect relative enrichment on dendritic spines.
Dendritic punctate colocalization of immunostaining was measured by generating segmented dendritic puncta masks showing discrete areas of continuous pixels of fluorescence intensity Ͼ50% above the mean dendritic fluorescence for AK AP150 and the marker of interest (i.e., PSD-95, F-actin, RII␤, C aN). Finally, a mask showing only areas of punctate dendritic colocalization for AK AP150 and the marker was generated using the "AND" f unction. Integrated intensity values were then calculated separately for the marker from this AK AP150 colocalization mask and the marker-specific dendritic puncta mask. The AK AP150 colocalization index for the marker was then generated by dividing the integrated intensities. These integrated colocalization indices (i.e., 150-RII co , 150-C aN co , PSD co ) calculated from multiple images for each condition are expressed as percentages Ϯ SEM in Results and bar graphs in the figures. Note, this method of quantitation, although more objective than manual counting of numbers of puncta, actually underrepresents true colocalization of puncta that are overlapping but have somewhat different sizes and shapes. Nonetheless, these colocalization indices clearly give a measure of the reproducibility of the data (as shown by small SEM values) and allow meaningf ul comparisons between different treatment conditions. In all measurements described above, the impacts of small variations in focus and volume in images are controlled for by sampling large numbers of similar structures and the normalization provided by using ratios.
Pharmacolog ical treatments of cultured neurons and COS7 cells. Neurons or C OS7 cells plated on coverslips (for immunocytochemistry) or Petri plates (for biochemical analysis) were incubated in normal growth media for all treatments. The various treatments are described in detail in Results and in the figure legends. Reagents were obtained from the Rat neonatal hippocampal neurons cultured at low density for the indicated number of days were stained for AKAP150 (red) and the postsynaptic density MAGUK PSD-95 ( green). The small panels are magnifications of dendrites. B, Punctate colocalization of AKAP79/150 with PSD-95 on dendritic spines: proximity of AKAP79/150 puncta to presynaptic terminals stained for synapsin but not inhibitory postsynaptic elements stained for GABA A receptors. Neurons (2-3 weeks old) cultured at medium-high density were stained with anti-rat AKAP150 (red) and anti-PSD-95, anti-synapsin, or anti-GABA A receptor (all in green). Codistribution is seen as yelloworange in composite images. The red and green arrowheads point to puncta for AKAP150 and PSD-95, respectively, that are not colocalized even in "mature" dendrites. The images shown are representative of multiple neurons imaged in more than three experiments for each condition.
following sources: L-glutamate, NMDA, AP-V, S-AM PA, and C NQX (Sigma / RBI, St. L ouis, MO); latrunculin A and jasplakinolide (Molecular Probes); cytochalasin D, H-89, bis-indomaleimide I, chelerthyrine (CH E), K N-62, cyclosporin A (C sA), F K506, rapamycin, and 5,6-dichloro-l-␤-ribof uranosylbenzimidazole (DRB) (C albiochem, La Jolla, CA). Electrophoresis reagents were from Bio-Rad. Other general chemicals and reagents were obtained from Sigma or Fisher Scientific (Houston, TX).
F-actin binding assay. Recombinant AKAP79WT, (1-153), and (154 -427) were expressed as His 6 -tagged fusion proteins [AKAP79 in pET16B; (1-153) and (154 -427) in pET30a] in Escherichia coli and purified by Ni-Agarose chromatography as described previously (Dell'Acqua et al., 1998) . However, (1-153) was His-tagged in pET30 at the C terminus in the current study, instead of the N terminus as in previous studies, to remove the N-terminal T7 epitope tag that contains exogenous phosphorylation sites. For actin-binding studies, N-His-AKAP79WT, N-His(154 -427), or (1-153)C-His was incubated with F-actin and then assayed for binding by cosedimentation. Briefly, F-actin was polymerized from purified G-actin (10 M; Sigma) in vitro for 30 min in 125 mM KCl, 2.5 mM MgCl 2 , 0.2 mM ATP, 2 mM Tris, pH 7.6 (F-Buffer). Actin (2 mg/ml) was stored at 4°C in the control G-buffer (0.2 mM ATP, 0.2 mM MgCl 2 , 2 mM Tris, pH 7.6). F-actin filaments or unpolymerized G-actin was then incubated for 10 min with AKAP79WT (700 ng), (1-153) (250 ng), or (154 -427) (500 ng) followed by centrifugation (20 min, 100,000 ϫ g). The distributions of the AKAP fragments between the supernatant containing G-actin (unbound fraction) and pellet containing F-actin (bound fraction) were determined by immunoblotting with rabbit anti-AKAP79 918I, 1:2000 (ICOS), and these immunoblots are shown in Figures 3B and 5 A , B,D. Regulation of (1-153) F-actin binding by PKC phosphor ylation and CaM binding. For actin binding regulation studies, (1-153)C -His was unphosphorylated or PKC phosphorylated with unlabeled ATP as described below or incubated 10 min with 1 M C aM (C albiochem) with (ϩ) or without (Ϫ) Ca 2ϩ (0.1 mM) or EGTA (5 mM), incubated with F-actin, and then assayed for actin binding by cosedimentation. For PKC phosphorylation order experiments, (1-153)C -His was either phosphorylated with PKC for 15 min as described above and then incubated with F-actin for 10 min or incubated with F-actin for 10 min before the addition of an equivalent amount of PKC for 15 min before centrif ugation (note: F-buffer already contains 0.2 mM ATP). For C aM-binding order experiments, (1-153)C -His was either incubated with 1 M C aM, 0.1 mM Ca 2ϩ for 10 min before incubation with F-actin for 10 min or incubated with F-actin for 10 min before the addition of 1 M C aM, 0.1 mM Ca 2ϩ for 10 min before centrif ugation.
In vitro phosphor ylation of the (1-153) targeting domain. Recombinant (1-153)C -His (1 g) was PKC phosphorylated essentially as described previously (Dell'Acqua et al., 1998) except for use of a PKC constitutively active catalytic trypsin fragment (PKC -M, 20 ng) (provided by Dr. Michael Browning, University of Colorado Health Science C enter). For direct visualization of PKC phosphorylation of (1-153)C -His, 600 cpm / pmol [␥Ϫ 32 P]ATP was included, and the reaction was then analyzed by SDS-PAGE and imaged using a Molecular Dynamics Storm Phosphorimager. To look at competition between C a 2ϩ -C aM binding and PKC phosphorylation, phosphorylation of (1-153) by PKC was done with or without 0.1 mM Ca 2ϩ , 5 mM EGTA, and 1 M C aM as indicated. Immunoprecipitation of A K A P79/150 comple xes f rom hippocampal neuron cell e xtracts. Hippocampal neurons cultured at high density were left untreated, treated with 5 M latrunculin A for 4 hr, or treated with 50 M NMDA for 10 min followed by washing twice in PBS. The cells from two to five (6 cm) dishes each for untreated control or treated conditions were pooled and lysed in 1-2 ml of 4°C Triton lysis buffer (TL B) (0.5% Triton X-100, 20 mM H EPES, pH 7.4, 0.1 M KC l, 30 mM NaPPi, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 2 g /ml leupeptin / pepstatin, 1 mM benzamidine, 1 mM 4-(2-aminoethyl)benzenesulfonylfluoride) followed by dounce homogenization to prepare whole-cell extracts. One hundred microliters of these whole-cell extracts for both untreated control and treated conditions were set aside. The remaining volumes of these extracts were clarified by centrif ugation (20,000 ϫ g, 15 min, 4°C). The resulting supernatants were divided into two to four separate tubes with equal protein contents, and then each tube was incubated at 4°C overnight with 5 g of rabbit anti-AK AP150 antibodies (IC OS). This incubation was followed by 1-2 hr incubation with protein A-Sepharose (25 l, 50% slurry equilibrated in TL B; UBI). The immune complexes were then pelleted by microcentrif ugation (3000 ϫ g, 1 min), and the beads were washed in TL B 6 ϫ 1 ml. The immune complexes were finally eluted with SDS-sample buffer, separated by SDS-PAGE along with cell extracts (12.5-25 g), and analyzed by immunoblotting with rabbit anti-AK AP150 (1:2000), mouse pan-anti-PSD -M AGUK family (1:1000, UBI), or mouse anti-PK A-RII␤ (1:2000; Transduction Labs).
RESULTS
Previous studies have demonstrated that AKAP79/150 is the major AKAP in the PSD (Carr et al., 1992) , coimmunoprecipitates with PSD-MAGUKs, and binds directly to both SAP97 and PSD-95 MAGUKs in vitro (Colledge et al., 2000) . Association of AKAP79 with MAGUKs in vitro involves direct binding between an unmapped central AKAP domain and the MAGUK SH3 and GK domains (Colledge et al., 2000) . However, proper membrane localization of these scaffolds clearly involves additional targeting determinants such as palmitoylation sites in PSD-95 and N-terminal basic regions in AKAP79 (Lue et al., 1994 (Lue et al., , 1996 Li et al., 1996; Dell'Acqua et al., 1998; Wu et al., 1998; Craven and Bredt, 2000; El-Husseini et al., 2000a) . Consistent with these independent targeting mechanisms, although AKAP79/150 shows extensive punctate colocalization with PSD-95 on dendritic spines in hippocampal neurons, it is also more widely distributed along dendrite spine and shaft membranes (Fig. 1) . Thus, the ability of AKAP79/150 to form scaffolding complexes with PSDMAGUKs at synapses in vivo is likely to depend first on the primary mechanisms that independently target the AKAP to plasma membranes and dendritic spines. We have previously identified three N-terminal basic regions that bind to PI-4,5-P 2 and are necessary and sufficient for targeting GFP to the plasma membrane in human embryonic kidney (HEK)-293 cells and cortical neurons (Dell'Acqua et al., 1998) . Each of these basic regions is similar to the basic effector domain of MARCKS that binds both membrane PI-4,5-P 2 and cortical F-actin (Aderem, 1992; Bubb et al., 1999; Wang et al., 2001) ; however, it is not known whether the AKAP79 targeting domain also binds F-actin. Although F-actin is not necessary for AKAP79 general membrane targeting in HEK-293 cells, it is quite possible that interactions with F-actin could further direct membranelocalized AKAP to more specific structures such as dendritic spines (Li et al., 1996; Dell'Acqua et al., 1998) . To evaluate this possibility, we conducted a developmental analysis of AKAP79/ 150 localization in low-density hippocampal neuron cultures across time periods when synapses first form and then mature into spiny actin-rich synapses.
Postsynaptic localization of AKAP79/150 on dendritic spines in hippocampal neurons
In neurons cultured for 8 DIV, AKAP79/150 showed nonuniform membrane localization in the soma and dendrites, including fine filopodial structures (Fig. 1 A) . However, at 8 DIV there was very little codistribution of AKAP79/150, with puncta for PSD-95 located primarily on dendritic shafts. By 16 DIV there was much more extensive colocalization of AKAP79/150 and PSD-95 puncta ( Fig. 1 A) . This somatodendritic colocalization of AKAP79/150 and PSD-95 developed more during the third week in culture, and by 22-26 DIV most PSD-95 puncta overlapped with AKAP79/150 puncta, especially on dendritic spines (Fig.  1 A) . However, even at 22-26 DIV there were still sites of AKAP79/150 staining that did not stain positive for PSD-95 and vice versa (Fig. 1 A; see arrowheads on magnification composite panels). Similar results were obtained in medium-high-density neuron cultures that form more numerous synapses and mature more rapidly than low-density cultures. Neurons cultured at mediumhigh density for 2-3 weeks showed extensive but still not complete dendritic colocalization of AKAP79/150 with PSD-95 ( Fig. 1 B , arrowheads) . Costaining of neurons for AKAP79/150 and synapsin reveals that most of the AKAP79/150 puncta seen in these dendrites are closely opposed to presynaptic terminals ( Fig. 1 B) . Specificity in this localization of AKAP79/150 to excitatory over inhibitory synapses was seen in very little overlap between dendritic AKAP79/150 and GABA A receptor puncta (Fig. 1 B) .
Postsynaptic localization of AKAP79/150 depends on the dendritic actin cytoskeleton
This developmental progression of AKAP79/150 colocalization with PSD-95 closely parallels time courses elucidated by others for the formation of F-actin-rich dendritic spines and recruitment of glutamate receptors and PSD-95 to spiny synapses (Rao et al., 1998; Pickard et al., 2000; Okabe et al., 2001; Zhang and Benson, 2001) . Importantly, postsynaptic localization of AMPA receptors depends on F-actin and is disrupted by the actin polymerization inhibitor latrunculin A (Allison et al., 1998 (Allison et al., , 2000 Shen et al., 2000; Zhou et al., 2001 ). In agreement with previous studies on AMPA receptors and as a positive control, treatment with latrunculin A caused decreased dendritic colocalization of GluR1-AMPA receptors with PSD-95 ( Fig. 2A) . Consistent with possible targeting of AKAP79/150 to postsynaptic actin, in untreated neurons AKAP79/150 exhibited colocalization with phalloidinstained F-actin and PSD-95 on dendritic spines ( Fig. 2 B, C) . After latrunculin treatment, AKAP79/150 assumed a more diffuse pattern in dendrites, with very little F-actin colocalization (Figs. 2 B, C). Importantly, treatment with latrunculin also disrupted AKAP79/150 codistribution with PSD-95 (Figs. 2 B, C) , which remained punctate, as seen in previous studies (Allison et al., 1998 (Allison et al., , 2000 . These effects of latrunculin on AKAP79/150 colocalization with F-actin and PSD-95 on dendritic spines were reversible after removal of the drug and a recovery period to allow repolymerization of spine actin (Fig. 2 B) . These findings indicate that, like AMPA receptors, the dendritic F-actin cytoskeleton is important for maintaining postsynaptic localization of AKAP79/150.
Quantitation of neurons from multiple experiments (n ϭ 3-5) revealed AKAP150-integrated colocalization indices (see Materials and Methods) of 65 Ϯ 9% for F-actin and 66 Ϯ 3% for PSD-95 (PSD co ) in untreated neurons. After latrunculin treatment, these indices fell to 22 Ϯ 6 and 19 Ϯ 6% for F-actin and PSD co , respectively. This loss of AKAP79/150 from the PSD might be expected to result in a corresponding change in localization of PKA and CaN anchored to it. In control neurons, both PKA-RII␤ and CaNB staining showed extensive punctate codistribution with AKAP79/150 on dendritic spines with colocalization indices of 150-RII co ϭ 73 Ϯ 4% and 150-CaN co ϭ 68 Ϯ 3%, respectively (Fig. 2 D) (n ϭ 3-5). However, after treatment of neurons with latrunculin, punctate codistribution of PKA and CaN with AKAP79/150 was lost, with all three proteins exhibiting primarily diffuse dendritic localization (Fig. 2 D) . Without numerous AKAP150, PKA-RII␤, or CaNB puncta to quantitate after latrunculin treatment, accurate colocalization indices could not be calculated. However, calculation of normalized mean fluorescence values (see Materials and Methods; D/T ratio) revealed corresponding 17-21% decreases in overall dendritic localization caused by latrunculin treatment for AKAP150 [81 Ϯ 3% Control; 63 Ϯ 3% latrunculin A (LtrA)], PKA-RII␤ (70 Ϯ 3% Control; 53 Ϯ 2% LtrA), and CaNB (76 Ϯ 4% Control; 55 Ϯ 3% LtrA), suggesting that a significant amount of PKA and CaN might be moving as a unit with the AKAP. Thus, the actin cytoskeleton is necessary for maintaining proper dendritic localization of multiple components of the AKAP79/150 scaffold.
The AKAP79 N-terminal basic domain binds F-actin and mediates targeting to the cortical membrane cytoskeleton in COS7 cells
In light of the results of these latrunculin studies and the similarities of the AKAP N-terminal basic domains with the MARCKS effector domain, we assayed purified recombinant AKAP79WT, an N-terminal targeting domain (1-153) fragment, and a C-terminal (154 -427) control fragment ( Fig. 3A) for direct binding to F-actin using cosedimentation methods. We observed direct binding of AKAP79 to F-actin as seen in cosedimentation of AKAP79 in the F-but not G-actin pellet fractions (Fig. 3B ). An additional control for nonspecific aggregation is that AKAP79 did not sediment in the absence of actin in either G-or F-buffer conditions. Importantly, a recombinant N-terminal (1-153) fragment corresponding to the previously mapped basic membrane targeting and PI-4,5-P 2 binding domain also exhibited specific cosedimentation with F-actin (Fig. 3B) . In contrast, a C-terminal (154 -427) control fragment lacking the basic domains but containing the CaN and PKA anchoring domains (Fig. 3A) did not cosediment with F-actin (Fig. 3B) .
We next sought to determine whether this N-terminal basic domain that binds F-actin in vitro might also be sufficient for targeting to the membrane actin cytoskeleton in a model cell system. We transfected COS7 cells with full-length AKAP79 tagged with GFP (Tsien, 1998) and then costained for F-actin with phalloidin (Fig. 3C) . In control cells, AKAP79 -GFP exhibited plasma membrane localization characterized by prominent enrichment with F-actin in membrane ruffles but not cytoplasmic stress fibers (Fig. 3C) . After disruption of F-actin with the polymerization inhibitor cytochalasin D, AKAP79 -GFP colocalization with F-actin was eliminated, and the AKAP assumed a diffuse plasma membrane localization with significant accumulation in intracellular membrane structures and aggregates (Fig.  3C) . Importantly, an N-terminal (1-153)-GFP protein also displayed specific localization to F-actin ruffles, and this localization was sensitive to disruption with cytochalasin D (Fig. 3D) . In contrast, a GFP-(150 -427) control fusion protein lacking the N-terminal basic domains was cytoplasmic and showed no localization with membranes or cortical actin in COS7 cells (Fig. 3E) . Thus, the N-terminal basic regions of AKAP79 appear to be necessary and sufficient for targeting to cortical/membrane actin structures in cells.
Our findings above suggest that inhibition of F-actin polymerization in neurons may disrupt dendritic spine localization of PKA and CaN through mislocalization of AKAP79/150. In support of this model, PKA-RII-GFP and mycCaNA subunits are cytoplasmic when expressed alone in COS7 cells (Figs. 3 F, G) but are targeted to the membrane and enriched in ruffles when coexpressed with AKAP79 ( Fig. 3 H, I ). Importantly, disruption of F-actin with cytochalasin D caused loss of membrane ruffle localization of PKA or CaN with AKAP79, diffuse plasma membrane localization, and the appearance of these proteins in intracellular structures (Figs. 3 H, I ). Thus, disrupting postsynaptic targeting of AKAP79/150, the predominant AKAP in the PSD, is likely to also alter dendritic spine localization of PKA and CaN in neurons as seen in Figure 2 . In addition, from the results of all of these COS7 studies, it seems reasonable that the diffuse dendritic localizations seen for AKAP79/150, PKA, and CaN in latrunculin-treated neurons is the product of both lateral membrane diffusion away from synapses as well as some redistribution to intracellular membranes.
Our previous studies showed that the AKAP79 basic targeting domains, like the MARCKS effector domain, could bind through nonspecific electrostatic interactions to membranes containing acidic phospholipids such as PI-4,5-P 2 . Interestingly, cellular imaging studies using PLC␦-PH, which binds with high affinity and specificity to PI-4,5-P 2 , have shown enrichment of PI-4,5-P 2 with actin in plasma membrane ruffles (Tall et al., 2000) . Thus, we wanted to examine whether the AKAP79 N-terminal basic domain might also colocalize with PI-4,5-P 2 in membrane ruffles. To make this inquiry possible, we generated AKAP79 full length and (1-153) tagged with cyan-CFP and the PLC␦-PH domain tagged with yellow-YFP for simultaneous imaging in live cells. Coexpression of either AKAP79 -CFP (Fig. 3J ) or (1-153)-CFP ( Fig. 3K ) with PLC␦-PH-YFP revealed extensive codistribution of CFP and YFP fluorescence in membrane ruffles of living COS7 cells. Some intracellular vesicular membrane localization of AKAP79 and (1-153)-CFP that was independent of PH-PLC␦-YFP was also seen (Fig. 3 J, K ) . However, the extensive overlap of AKAP79(1-153) with PLC␦-PH in ruffles clearly shows significant enrichment of the AKAP targeting domain and PI-4,5-P 2 in the same plasma membrane structures. These findings suggest that multiple electrostatic interactions of the three AKAP79 N-terminal basic regions, like the MARCKS basic domain, may allow the AKAP to link plasma membrane PI-4,5-P 2 to cortical actin in ruffles.
The AKAP79 N-terminal basic domain mediates targeting to dendritic spines in hippocampal neurons
We next wanted to establish that this same N-terminal basic region that targeted to cortical actin and PI-4,5-P 2 membrane structures in COS7 cells was also involved in targeting AKAP79 to dendritic spines in neurons. Previously, we demonstrated that this region could target to somatodendritic plasma membranes in microinjected cortical neurons; however, specific colocalization with F-actin or PSD-MAGUKs at synapses was not addressed (Dell'Acqua et al., 1998) . Expression of either full-length AKAP79 -GFP or (1-153)-GFP containing just the N-terminal basic domain resulted in targeting of GFP to plasma membrane sites in both the soma and dendrites of transfected neurons (Fig.  4 A) . In contrast, GFP alone was clearly cytoplasmic and diffusely distributed throughout the soma and dendrites (Fig. 4 A) . Dendritic localization of both AKAP79 and (1-153) was characterized by punctate enrichment on dendritic spines (Fig. 4 A) , where colocalization with F-actin or PSD-95 could be seen (Fig. 4 B) . Enrichment on dendritic spines was quantitated by 30 -50% higher average spine/shaft normalized mean fluorescence ratios for AKAP79 (1.55 Ϯ 0.1; n ϭ 10) and (1-153)-GFP (1.33 Ϯ 0.03; n ϭ 13) relative to GFP alone (1.05 Ϯ 0.06; n ϭ 11), which showed equal distribution between dendritic spines and shafts. These findings suggest that the N-terminal basic domain is sufficient for targeting AKAP79 to dendritic spines in hippocampal neurons.
Regulation of AKAP79 targeting domain binding to F-actin by phosphorylation and calmodulin binding
The three basic regions of the AKAP79 targeting domain contain serine/threonine phosphorylation sites and bind Ca 2ϩ -CaM (Faux and Scott, 1997; Dell'Acqua et al., 1998) . We have shown previously that in vitro binding of the AKAP79(1-153) targeting domain to PI-4,5-P 2 is regulated by PKC phosphorylation and Ca 2ϩ -CaM binding (Dell'Acqua et al., 1998) . Thus, it is likely that binding of the AKAP79 targeting domain to F-actin is also regulated by PKC and CaM. Consistent with these expectations, preincubation of AKAP79(1-153) with CaM in the presence of Ca 2ϩ inhibited binding to F-actin in the cosedimentation assay (Fig. 5A ). This inhibitory effect of CaM was Ca 2ϩ dependent and not observed in the absence of Ca 2ϩ plus the chelator EGTA. Also in agreement with earlier work, previous phosphorylation of (1-153) with PKC (readily seen in electrophoretic mobility shifts) also inhibited F-actin cosedimentation (Fig. 5B) . For the MARCKS protein, PKC phosphorylation of the effector domain and Ca 2ϩ -CaM binding, both of which regulate targeting function, are competitive with one another (Aderem, 1992) . To evaluate this possibility for AKAP79, we phosphorylated (1-153) with PKC in the presence of Ca 2ϩ -CaM. PKC phosphorylation was significantly inhibited by Ca 2ϩ -CaM but not CaM and EGTA (Fig. 5C ). These findings suggest that CaM binding to the AKAP basic targeting domain blocks access to sites phosphorylated by PKC. Thus, in cells it is possible that phosphorylation, multiple CaM binding events, or some combination of both processes acting through the three basic regions may regulate AKAP79 membrane/cytoskeletal interactions in response to Ca 2ϩ signals.
F-actin competes with phosphorylation and calmodulin binding in regulation of the AKAP79 targeting domain
Because F-actin binding, phosphorylation, and CaM binding all converge on the same three basic regions, it is possible that when the targeting domain is bound to cortical actin in cells the basic regions may not be readily accessible for phosphorylation or CaM binding. Such a scenario would explain why in previous studies activation of PKC or CaM released very little AKAP79 from HEK-293 membrane fractions (Dell'Acqua et al., 1998). To test this idea biochemically, we varied the order of incubations of the (1-153) targeting domain with PKC or Ca 2ϩ -CaM and F-actin. In agreement with results presented above, under control conditions most of (1-153) sedimented with F-actin, and phosphorylation of (1-153) with PKC or incubation with Ca 2 -CaM before incubation with F-actin strongly inhibited this sedimentation (Fig.  5D ). In contrast, previous incubation of (1-153) with F-actin significantly attenuated the ability of PKC or Ca 2ϩ -CaM to then release the targeting domain from F-actin, as seen in nearly equal distributions between the supernatants and pellets (Fig. 5D) . Overall, these findings help confirm that the same basic regions that mediate membrane targeting and PI-4,5-P 2 binding also regulate interactions with F-actin.
Glutamate regulation of dendritic F-actin and AKAP79/150 postsynaptic targeting
On the basis of observations that AKAP79 targeting may be subject to regulation by Ca 2ϩ signals as well as actin polymerization, we wanted to see whether postsynaptic localization of AKAP79/150 could be regulated by neuronal signaling pathways that elevate Ca 2ϩ and reorganize the dendritic actin cytoskeleton. We treated cultured neurons with 50 M glutamate for 10 min and then fixed and stained to visualize localization of AKAP79/150 relative to F-actin, PSD-MAGUKs (including both PSD-95 and SAP97; pan-PSD-MAGUK antibody), and synapsin (Fig. 6) . Similar glutamate treatments of hippocampal neurons have been shown to stimulate rapid AMPA receptor endocytosis and reorganization of dendritic F-actin (Halpain et al., 1998; Carroll et al., 1999b; Lissin et al., 1999; Beattie et al., 2000; Zhou et al., 2001) . Consistent with earlier studies, exposure to glutamate led to a reorganization of F-actin in the dendrites manifested by loss of F-actin puncta on dendritic spines and increased actin filament staining along dendrite shafts (Fig. 6 A) (Halpain et al., 1998) . Also in agreement with previous work, treatment with glutamate did not drastically alter punctate distribution of the postsynaptic MAGUKs (Fig. 6 B) or presynaptic terminals marked by synapsin (Fig. 6C) (Halpain et al., 1998) . Glutamate treatment also caused a dramatic redistribution of AKAP79/150 seen as loss of somatodendritic puncta, weak and diffuse staining in dendrite shafts, and increased fluorescence in the cytoplasm of the soma (Fig. 6 A) . This shift in localization of AKAP79/150 from dendrites to the soma was reflected in decreased dendritic fluorescence (D/T ϭ 89 Ϯ 2% control, n ϭ 6; D/T ϭ 56 Ϯ 4% glutamate, n ϭ 5) and increased somatic fluorescence (S/T ϭ 131 Ϯ 6% control; S/T ϭ 175 Ϯ 7% glutamate) that can be expressed together as a decreased ratio of mean dendritic to somatic fluorescence (D/S ϭ 69 Ϯ 4% control; D/S ϭ 32 Ϯ 2% glutamate). Importantly, this glutamate-stimulated re- distribution of AKAP79/150 resulted in loss of colocalization with PSD-MAGUKs (Fig. 6 B) (see below) and synapsin (Fig. 6C) .
Regulation of AKAP79/150 postsynaptic localization by NMDA receptor activation
Both reorganization of dendritic spine F-actin and endocytosis of AMPA receptors can be triggered by activation of either NMDA or AMPA receptors alone (Halpain et al., 1998; Carroll et al., 1999b; Beattie et al., 2000; Lin et al., 2000; Man et al., 2000; Zhou et al., 2001) . However, for regulation of some important forms of hippocampal LTD, Ca 2ϩ influx through NMDA receptors is thought to be the key signaling event. In agreement with previous studies and as a positive control for NMDA receptor regulation of AMPA receptors, NMDA treatment clearly disrupted dendritic colocalization of GluR1 with PSD-95 (Fig. 7A) . As shown above, in untreated neurons, AKAP79/150 showed significant codistribution with PSD-95 (PSD co ϭ 64 Ϯ 3%; n ϭ 6), and treatment with glutamate led to rapid redistribution of AKAP79/ 150 from dendrites (D/S ϭ 32 Ϯ 2%) manifested in loss of dendritic colocalization with PSD-95 (PSD co ϭ 8 Ϯ 3%; n ϭ 5) (Fig. 7 B, C) . Brief preincubation of neurons in the presence of EGTA to chelate extracellular Ca 2ϩ mostly prevented glutamatestimulated redistribution of AKAP79/150 from dendrites (D/S ϭ 69 Ϯ 4%) and maintained colocalization with PSD-95 (PSD co ϭ 56 Ϯ 5%; n ϭ 5) (Fig. 7C ). Consistent with a predominant role for Ca 2ϩ influx through NMDA receptors in this response, glutamate-stimulated redistribution of AKAP79/150 was blocked by the NMDA receptor antagonist AP-V (100 M; D/S ϭ 65 Ϯ 6%; PSD co ϭ 62 Ϯ 4%; n ϭ 6), with no obvious additional effect seen with addition of the AMPA receptor antagonist CNQX (50 M; D/S ϭ 63 Ϯ 2%; PSD co ϭ 67 Ϯ 8%; n ϭ 3) (Fig. 7 B, C) . Furthermore, selective activation of NMDA receptors with 50 M NMDA was sufficient to cause redistribution of AKAP79/150 away from postsynaptic specializations (D/S ϭ 40 Ϯ 4%; PSD co ϭ 7 Ϯ 2%; n ϭ 7) in an AP-V-sensitive manner (D/S ϭ 64 Ϯ 4%; PSD co ϭ 58 Ϯ 3%; n ϭ 12) (Fig. 7 B, C) . Thus, our conclusion is that NMDA receptor activation is both necessary and sufficient for activation of Ca 2ϩ -dependent signaling pathways regulating localization of AKAP79/150 to postsynaptic sites.
Activation of the phosphatase calcineurin but not protein kinases is necessary for NMDA receptor regulation of AKAP79/150 targeting
One potentially important target of Ca 2ϩ influx that has been implicated in NMDA receptor regulation of dendritic spine F-actin and AMPA receptor localization is the Ca 2ϩ -activated phosphatase CaN-PP2B (Halpain et al., 1998; Beattie et al., 2000; Ehlers, 2000) . It is possible that CaN stimulation of dendritic spine F-actin remodeling could have an active role in regulating the AKAP79/150 cytoskeletal linkage that maintains it at synapses. In agreement with this hypothesis, inhibition of CaN with either CsA (D/S ϭ 47 Ϯ 4%; PSD co ϭ 46 Ϯ 4%; n ϭ 8) or FK506 (D/S ϭ 50 Ϯ 3%; PSD co ϭ 55 Ϯ 3%; n ϭ 9) mostly prevented NMDA-regulated redistribution of AKAP79/150 when compared with untreated (control D/S ϭ 57 Ϯ 3%; PSD co ϭ 61 Ϯ 2%; n ϭ 14) and NMDA-treated cells (NMDA D/S ϭ 37 Ϯ 3%; PSD co ϭ 4 Ϯ 1%; n ϭ 10) (Fig. 8 A, B) . No effects were seen in NMDA-treated cells with rapamycin, a drug that binds to immunophilins like CsA and FK506 but does not inhibit CaN (data not shown). Importantly, CaN is directly anchored to AKAP79/150 and thus may be optimally positioned to participate in regulation of the postsynaptic actin cytoskeleton in response to NMDA receptor activation. However, NMDA receptor Ca 2ϩ signaling can also activate kinases such as PKC, CaMKII, and PKA (through Ca 2ϩ -regulated adenylyl cyclase). Furthermore, previous work and studies presented above show that PKC phosphorylation of the AKAP79 targeting domain can regulate PI-4,5-P 2 and F-actin binding in vitro (Fig. 5) (Dell'Acqua et al., 1998) . However, consistent with a dependence on phosphatases and not kinases, NMDA-mediated AKAP79/150 redistribution was insensitive to inhibition of PKC with chelerythrine-CHE (D/S ϭ 34 Ϯ 3%; PSD co ϭ 5 Ϯ 2%; n ϭ 5), CaMKII with KN-62 (D/S ϭ 29 Ϯ 2%; PSD co ϭ 5 Ϯ 1%, n ϭ 3), or PKA with H-89 (D/S ϭ 33 Ϯ 3%; PSD co ϭ 5 Ϯ 2%; n ϭ 4) (Fig. 8 B) .
Reorganization of dendritic spine F-actin is necessary for NMDA receptor regulation of AKAP79/150 postsynaptic localization NMDA receptor activation of CaN-regulated F-actin remodeling could certainly control localization of AKAP79/150, as shown above by inhibition of actin polymerization with latrunculin disrupting AKAP79/150 postsynaptic targeting (Fig. 2) . However, although F-actin reorganization accompanies redistribution of AKAP79/150 after glutamate or NMDA treatment (Fig. 6 A) (data not shown), the AKAP does not appear to move directly with F-actin in these experiments. Nonetheless, it is possible that actin remodeling in response to NMDA receptor activation is a necessary first step allowing AKAP release from the PSD and lateral membrane diffusion followed by secondary redistribution (see below) away from the membrane. To test whether reorganization of F-actin is in fact necessary for NMDA receptorregulated redistribution of AKAP79/150, we pretreated neurons with jasplakinolide, a drug that stabilizes F-actin filaments and prevents NMDA-induced reorganization of dendritic spine F-actin (Halpain et al., 1998) . Pretreatment with jasplakinolide for 2 hr prevented (D/S ϭ 59 Ϯ 3%; PSD co ϭ 46 Ϯ 4%; n ϭ 7) NMDA-mediated redistribution of AKAP79/150 away from PSD-95 (D/S ϭ 37 Ϯ 3%; PSD co ϭ 4 Ϯ 1%; n ϭ 10), similar to inhibition of CaN (see above), and nearly as well receptor block with AP-V (D/S ϭ 64 Ϯ 4%; PSD co ϭ 58 Ϯ 3%; n ϭ 12) (Fig.  8 A, B) . Thus, remodeling of F-actin in response to CaN activation is likely to untether the AKAP79/150 targeting domain from the postsynaptic cytoskeleton. These results taken together with the insensitivity to kinase inhibition are most consistent with a model in which F-actin reorganization makes the targeting domain accessible for subsequent Ca 2ϩ -CaM binding (Fig. 5D) . CaM binding could then mediate secondary redistribution of AKAP79/ 150 away from the plasma membrane as well as prevent reassociation with dendritic F-actin after NMDA receptor activation. Unfortunately, this predicted secondary involvement of CaM binding in AKAP79/150 translocation cannot be investigated with CaM inhibitors because they also inhibit CaN activation.
Inhibition of actin polymerization and NMDA receptor activation both regulate association of the AKAP79/ 150-PKA complex with PSD-MAGUKs
Immunocytochemistry presented above shows that inhibition of actin polymerization and NMDA receptor activation both cause loss of AKAP79/150 from synapses, suggesting dissociation from PSD-MAGUK complexes. To independently confirm disassembly of AKAP79/150 -MAGUK complexes, we immunoprecipitated AKAP79/150 from cell extracts prepared from neurons treated with latrunculin or NMDA and analyzed the immunoprecipitates by immunoblotting for AKAP150, PSD-MAGUKs (pan-PSD-MAGUK antibody), and PKA-RII␤ subunits. The levels of AKAP79/150, PSD-MAGUKs, and PKA-RII␤ were (Figure legend continues.) essentially the same in cell extracts prepared from untreated control neurons and latrunculin-or NMDA-treated neurons, indicating that there was no significant proteolytic loss of these proteins resulting from the treatments (Fig. 9A,B) . Roughly equal amounts of AKAP150 and PKA-RII␤ were detected in AKAP150 immunoprecipitates from control and latrunculin-or NMDA-treated neurons, indicating that the AKAP-PKA complex is still intact after these treatments (Fig. 9 A, B) . In contrast, PSD-MAGUK proteins, which are readily seen coprecipitating with AKAP150 from control neurons, are not detectable in AKAP150 precipitates from latrunculin-or NMDA-treated neurons (Fig. 9 A, B) , even after long exposures (data not shown). Thus, reorganization of F-actin caused by either latrunculin treatment or NMDA receptor activation leads not only to altered subcellular targeting of AKAP79/150 seen by immunocytochemistry but also to disruption of AKAP-MAGUK complexes detected biochemically. Disruption of AKAP-MAGUK complexes should in turn break AKAP79/150 linkage to glutamate receptors. Although we were unable to address this question directly by coprecipitation because of the small amounts of extract obtained from cultured neurons, our immunocytochemistry supports this prediction. Latrunculin A and NMDA both trigger loss of AKAP79/150 and GluR1 colocalization with PSD-95, but GluR1 remains punctate, consistent with trafficking to endosomes (Ehlers, 2000) , whereas AKAP79/150 becomes more diffuse and untargeted (Figs. 2, 7) .
NMDA receptor regulation of AKAP79/150 postsynaptic targeting and redistribution of PKA and CaN
An additional prediction that is supported by our results showing equal coprecipitation of AKAP150 and PKA-RII␤ after latrunculin or NMDA treatment is that anchored PKA may be redistributing from dendritic spines in a complex with AKAP79/150. As shown above (Fig. 2) , in untreated cells PKA-RII␤ showed extensive punctate codistribution with AKAP79/150 on dendritic spines (150-RII co ϭ 68 Ϯ 6%; n ϭ 7) (Fig. 10 A) . PKA-RII␤ also displayed independent localization in cell bodies and proximal dendritic shafts, probably reflecting anchoring to other AKAPs in those locations (Fig. 10 A) . After treatment with glutamate, RII␤ and AKAP79/150 became diffuse and punctate dendritic spine colocalization was lost, with insufficient puncta for either protein remaining for quantitation (Fig. 10 A) . However, in response to glutamate, dendritic fluorescence decreased for both AKAP79/ 150 (control D/T ϭ 83 Ϯ 2%, n ϭ 6; glutamate D/T ϭ 51 Ϯ 2%, n ϭ 5) and RII␤ (control D/T ϭ 67 Ϯ 2%; glutamate D/T ϭ 54 Ϯ 2%) (Fig. 10 A) . After all treatments, the prominent localization of RII␤ in the soma and proximal dendritic shafts was unaltered, suggesting that NMDA receptor activation selectively regulated localization of a pool of PKA bound to AKAP79/150. Importantly, the NMDA receptor antagonist AP-V inhibited the effects of glutamate on RII␤ and AKAP79/150 localization (RII D/T ϭ 77 Ϯ 4%; AKAP150 D/T ϭ 86 Ϯ 2%) and spine colocalization (150-RII co ϭ 50 Ϯ 7%; n ϭ 4) (Fig. 10 A) .
From the results presented in Figure 8 , redistribution of AKAP79/150 involves activation of CaN. Anchoring of the CaN A, B holoenzyme to AKAP79/150 is mediated through binding of catalytic CaNA subunit in a manner that noncompetitively inhibits phosphatase activity (Coghlan et al., 1995; Dell'Acqua et al., 1998; Kashishian et al., 1999) . Thus, we wanted to see whether the AKAP-CaN interaction might be regulated by the NMDA receptor. Unfortunately, our efforts to look for release of CaN from AKAP79/150 by immunoprecipitation were unsuccessful because of limitations of CaN antibody sensitivities and small amounts of extracts obtained from cultured neurons (data not shown). Nonetheless, regulation of the CaN-AKAP79/150 interaction by NMDA receptor activation might be manifested in changes in the dendritic localization of CaN relative to the AKAP. Others have observed changes in the pattern of CaNA subunit staining in hippocampal neurons after NMDA and glutamate treatments similar to those used here (Halpain et al., 1998) . In untreated neurons, CaNB and AKAP79/150 showed punctate colocalization (150-CaN co ϭ 58 Ϯ 2%; n ϭ 6) on dendritic spines ( Fig.  10 B) ; however, CaN was distributed more extensively throughout the cytoplasm of the cell body. Treatment of neurons with glutamate disrupted punctate dendritic spine colocalization of AKAP79/150 and CaNB (150-CaN co ϭ 3 Ϯ 1%; n ϭ 8), with the AKAP redistributing to a diffuse localization in dendrites and the soma as observed above (control D/T ϭ 74 Ϯ 3%, D/S ϭ 50 Ϯ 3%, S/T ϭ 149 Ϯ 7%; glutamate D/T ϭ 42 Ϯ 2%, D/S ϭ 22 Ϯ 1%, S/T ϭ 190 Ϯ 8%) (Fig. 10 B) . AP-V pretreatment inhibited the glutamate-regulated redistribution of AKAP79/150 (D/T ϭ 66 Ϯ 3%, D/S ϭ 40 Ϯ 3%, S/T ϭ 168 Ϯ 6%) relative to CaNB (150-CaN co ϭ 44 Ϯ 3%; n ϭ 6), thus confirming involvement of NMDA receptors (Fig. 10 B) . In response to glutamate, punctate CaNB staining certainly decreased (ϳ45%); however, unlike AKAP and PKA, overall CaNB staining remained distributed in dendrites and did not concentrate any more in soma in glutamatetreated (D/T ϭ 64 Ϯ 4%, D/S ϭ 41 Ϯ 4%, S/T ϭ 155 Ϯ 7%) versus untreated neurons (D/T ϭ 67 Ϯ 4%, D/S ϭ 43 Ϯ 3%, S/T ϭ 159 Ϯ 8%) (Fig. 10 B) . Disruption of AKAP79/150 -CaN colocalization on dendritic spines without coincident CaN movement from dendrites to the soma could be indicative of CaN release from the AKAP. However, an alternative explanation is that CaN is simply in excess of AKAP in dendrites. Nonetheless, NMDA receptor regulation of AKAP79/150 -PKA localization (Fig. 10 A) is also accompanied by distinct changes in colocalization with CaN (Fig. 10 B) .
DISCUSSION
We show that AKAP79/150 localization to excitatory synapses requires the actin cytoskeleton. Postsynaptic cytoskeletal tethering of AKAP79/150 is likely to involve N-terminal basic regions that bind F-actin, acidic phospholipids and target to membrane Earlier studies of AKAP79/75 localization in HEK-293 cells suggested that cortical F-actin was not necessary for membrane targeting (Li et al., 1996; Dell'Acqua et al., 1998) . Indeed, AKAP79 can bind to phospholipid vesicles supporting direct membrane association (Dell'Acqua et al., 1998) . In fact, even in our COS7 studies after cytochalasin D treatment, we see diffuse plasma membrane localization as well as more prominent intracellular membrane localization of AKAP79 consistent with phospholipid binding. However, although previous studies in HEK-293 cells also detected AKAP79/75 membrane targeting after cytochalasin D treatment, they did not explore actin requirements for more specific localization to ruffles. Failure to appreciate the F-actin dependence of AKAP79 localization in earlier studies might also be related to differences in morphology between COS7 versus HEK-293 cells, the latter of which are more round and less ruffled.
Our current findings clearly show that retention of AKAP79/ 150, PKA, and CaN at specialized actin-rich membrane structures in both COS7 cells and neurons depends on F-actin. Furthermore, we find that AKAP79/150 postsynaptic scaffolding interactions with PSD-MAGUKs depends first on proper AKAP membrane/F-actin targeting. We find that NMDA receptor activation, which reorganizes dendritic actin, causes a rapid redistribution of the AKAP79/150-PKA complex away from PSDMAGUKs. Analysis of this AKAP79/150 regulation revealed a dependency on Ca 2ϩ influx that is likely to involve activation of a previously characterized pathway involving the phosphatase CaN and F-actin remodeling (Halpain et al., 1998) .
Similar mechanisms of AKAP79/150 and AMPA receptor synaptic localization
Interestingly, the targeting mechanisms that we have elucidated for AKAP79/150 are remarkably similar to those investigated by others for AMPA receptors that can be linked to the AKAP through SAP97 (Colledge et al., 2000) . For example, AKAP79/ 150 and AMPA receptor postsynaptic localization are both disrupted by inhibiting actin polymerization with latrunculin and maintained by stabilizing F-actin with jasplakinolide (Allison et al., 1998 (Allison et al., , 2000 Shen et al., 2000; Zhou et al., 2001) . AMPAGluR1 and SAP97 both bind to 4.1N/G-actin binding proteins, providing possible linkage to the cytoskeleton (Lue et al., 1994 (Lue et al., , 1996 Wu et al., 1998; Shen et al., 2000) . However, our findings suggest that AKAP79/150 might provide another point of attachment to spine actin for SAP97-GluR1 complexes. Importantly, recruitment of AMPA receptors to synapses during LTP in response to NMDA receptor and CaMKII activation requires the GluR1 C-terminal PDZ-binding site recognized by SAP97 (Leonard et al., 1998; Hayashi et al., 2000; Passafaro et al., 2001; Shi et al., 1999 Shi et al., , 2001 ) as well as F-actin (Kim and Lisman, 1999; Krucker et al., 2000) . Thus, AKAP79/150 binding to F-actin and SAP97 may play a role in synaptic delivery of AMPA-GluR1 receptors, a process that seems to correlate with PKA phosphorylation (Ehlers, 2000; . AKAP79/150 is also linked to NMDA receptors through PSD-95 binding to NR2A/B (Colledge et al., 2000) . However, although PSD-95 and NMDA receptors are also linked to the actin cytoskeleton, synaptic localization of PSD-95 and NMDA receptors does not require F-actin and is not rapidly regulated by glutamate (Allison et al., 1998 (Allison et al., , 2000 Carroll et al., 1999b; Lissin et al., 1999) . Nonetheless, AKAP79/150 complexes with PSD-95 could be important for regulating not only NMDA receptors but also nearby AMPA receptors independent of linkage through SAP97. Indeed, mice lacking functional PSD-95, although having normal NMDA receptor localization, exhibit abnormal hippocampal synaptic plasticity characterized by enhanced LTP and no LTD, indicating altered coupling to pathways regulating AMPA receptors (Migaud et al., 1998) . One way in which PSD-95 may regulate AMPA receptor localization is through PDZ binding to AMPA receptor-associated Stargazin (Chen et al., 2000; El-Husseini et al., 2000b) . Thus, the AKAP79/150 scaffold might also be linked to AMPA receptors through PSD-95.
NMDA receptor regulation of AKAP79/150 and AMPA receptor localization by signaling pathways shared with LTD Importantly, we demonstrate that association of AKAP79/150-PKA with PSD-MAGUKs is regulated by NMDA receptor signaling pathways that also control synaptic targeting of AMPA receptors. Work by others has implicated NMDA activation of CaN in the regulation of endocytosis and dephosphorylation of Figure 9 . Regulation of AKAP79/150-PKA association with PSDMAGUKs by inhibition of actin polymerization and NMDA receptor activation. A, Inhibiting F-actin polymerization with latrunculin A disrupts association of AKAP79/150 with PSD-MAGUKs but not PKA in complexes isolated from hippocampal neuron cell extracts. B, NMDA receptor activation disrupts association of AKAP79/150 with PSDMAGUKs but not PKA in complexes isolated from hippocampal neuron cell extracts. Neurons grown at high density on Petri plates were either untreated for control conditions or treated with latrunculin A (ϩLtrA; 5 M, 4 hr) ( A) or NMDA (50 M, 10 min) (B) before harvesting and lysis to prepare whole-cell extracts. AKAP79/150 was then immunoprecipitated (IP: AK AP150) from Triton X-100-soluble fractions prepared from these extracts. The immunoprecipitates and whole-cell extracts were then analyzed by immunoblotting (IB:) for AKAP150, PSD-MAGUK family members, and the PKA-RII␤ regulatory subunit as indicated. The data shown are representative of three experiments done on two to four samples for each condition.
PKA-phosphorylated AMPA receptors through mechanisms thought to be shared with LTD (Carroll et al., 1999a; Beattie et al., 2000; Ehlers, 2000) . In Figure 11 , we summarize our findings for regulation of AKAP79/150 localization and speculate how they might relate to AMPA receptor modulation. Under basal conditions, AKAP79/150 -SAP97-AMPA receptor complexes may be stabilized at the synaptic membrane by interactions of the AKAP targeting domain and GluR1-SAP97-4.1 complexes with F-actin (Fig. 11 A) . Any CaN present in these receptor complexes would be inhibited at least partially by the AKAP (Coghlan et al., 1995; Dell'Acqua et al., 1998; Kashishian et al., 1998) . In this context, PKA activity anchored to AKAP79/150 may be sufficient to maintain basal phosphorylation of AMPA-GluR1 on Ser 845 (Fig. 11 A) . However, this balance of PKA and CaN activity may be quite dynamic, as seen in studies showing that disruption of PKA anchoring with AKAP inhibitor peptides in hippocampal neurons decreases AMPA receptor activity through CaN-PP1 pathways (Tavalin et al., 2002) . In addition, AKAP79-anchored PKA and CaN have been shown to bidirectionally regulate activity and phosphorylation of SAP97-linked GluR1 on Ser845 in transfected cells in an LTD-like manner (Colledge et al., 2000; Tavalin et al., 2002) . As mentioned above, AKAP79/150 is also present in membrane complexes with NMDA receptors, PSD-95, and F-actin that could serve similar functions for regulation of AMPA receptors not linked to SAP97 (Sans et al., 2001) .
After treatment of neurons with glutamate/NMDA, influx of Ca 2ϩ through NMDA receptors would trigger activation of CaM and CaN, which may be activated to a low level bound to the AKAP, be in excess of the AKAP, or be released from the AKAP (Fig. 11 B) . In any case, CaN activation leading to local reorganization of F-actin would untether the AKAP from the cytoskeleton, thereby disrupting AKAP complexes with MAGUKs, including SAP97 and PSD-95 (Fig. 11C ). This untethering may allow lateral diffusion and then release of the AKAP from the membrane and PI-4,5-P 2 through a secondary process that could involve Ca 2ϩ -CaM binding to the targeting domain (Dell'Acqua et al., 1998) (Fig. 11C) . Loss of AKAP79/150-anchored PKA from the synapse, like disruption of PKA anchoring with inhibitor peptides, would favor dephosphorylation events mediated by CaN and synapseanchored PP1 (Mulkey et al., 1994; Rosenmund et al., 1994; Blitzer et al., 1998; Morishita et al., 2001; Tavalin et al., 2002) . Moreover, movement of the inhibitory AKAP would favor increased synaptic CaN activation. The actions of phosphatases on GluR1 itself, as well as endocytic proteins such as dynamin, might favor GluR1-Ser845 dephosphorylation coincident with recruitment of AMPA receptors to clathrin-coated pits for removal by endocytosis (Fig.  11C) (Carroll et al., 1999b; Lai et al., 1999; Lin et al., 2000; Man et al., 2000; Beattie et al., 2000; Ehlers, 2000) .
A very similar sequential model of untethering from actin followed by endocytosis has been proposed by others to explain the mechanism of loss of AMPA receptors from synapses in response to glutamate/NMDA or latrunculin treatment of cultured neurons (Zhou et al., 2001) . Although the mechanistic links 
